Reuters logo
BRIEF-Teva announces FDA approval of AUSTEDO tablets for treatment of chorea associated with huntington’s disease
2017年4月3日 / 晚上9点11分 / 8 个月前

BRIEF-Teva announces FDA approval of AUSTEDO tablets for treatment of chorea associated with huntington’s disease

April 3 (Reuters) - Teva Pharmaceutical Industries Ltd -

* Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with huntington’s disease

* AUSTEDO is expected to be available in U.S. within next 3 weeks. Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below